Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

DYNDYN
Showing 8 of 23 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in DYNE THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 1.2M shares of DYN (DYNE THERAPEUTICS INC), worth $26.7M as of 2026-Q2. The position was increased (+3.8% shares). DYN represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$26.7M

Current Shares

1.2M

Total Value Change

+$3.4M

Total Shares Change

+553,551

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+3.8%
$26.7M0.0%$22.21
30
2026-Q1
Increased
1.2M
+0.6%
$21M0.0%$14.60
29
2025-Q4
Increased
1.2M
+14.3%
$22.5M0.0%$19.20
33
2025-Q3
Increased
1M
+35.2%
$12.7M0.0%$12.37
36
2025-Q2
Increased
745,071
+13.9%
$7.1M0.0%$9.57
31
2025-Q1
Decreased
654,131
-2.0%
$6.8M0.0%$11.45
0
2024-Q4
Increased
667,452
+2.9%
$15.7M0.0%$23.65
29
2024-Q3
Increased
648,652
+7.9%
$23.3M0.0%$33.83
31

Other major holders of DYN: BlackRock, Inc., Janus Henderson Group Ltd., BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used